Tanabe N, Shimizu K, Terada K, et al. Central airway and peripheral lung
structures in airway disease dominant COPD. ERJ Open Res 2021;:00672–2020.
doi:10.1183/23120541.00672-2020
2020 Gold Reports - Global Initiative for Chronic Obstructive Lung Disease GOLD. https://goldcopd.org/gold-reports/ (accessed 1 Feb 2021).
Suzuki M, Makita H, Konno S, et al. Asthma-like Features and Clinical Course
of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido
COPD Cohort Study. Am J Respir Crit Care Med 2016;194:1358–65.
doi:10.1164/rccm.201602-0353OC
Suzuki M, Makita H, Konno S, et al. Annual change in FEV1 in elderly 10-year
survivors with established chronic obstructive pulmonary disease. Sci Rep
2019;9:2073. doi:10.1038/s41598-019-38659-8
Shimizu K, Tanabe N, Tho N Van, et al. Per cent low attenuation volume and
fractal dimension of low attenuation clusters on CT predict different long-term
outcomes in COPD. Thorax 2020;75:116–22. doi:10.1136/thoraxjnl-2019213525
Makita H, Suzuki M, Konno S, et al. Unique Mortality Profile in Japanese
Patients with COPD: An Analysis from the Hokkaido COPD Cohort Study. Int J
Chron Obstruct Pulmon Dis 2020;15:2081–90. doi:10.2147/COPD.S264437
Suzuki M, Makita H, Ito YM, et al. Clinical features and determinants of COPD
exacerbation in the Hokkaido COPD cohort study. Eur Respir J 2014;43:1289–
97. doi:10.1183/09031936.00110213
Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function
and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir
Crit Care Med 2012;185:44–52. doi:10.1164/rccm.201106-0992OC
Kirby M, Tanabe N, Tan WC, et al. Total Airway Count on Computed
Tomography and the Risk of Chronic Obstructive Pulmonary Disease
Progression. Findings from a Population-based Study. Am J Respir Crit Care
Med 2018;197:56–65. doi:10.1164/rccm.201704-0692OC
10
Han MK, Tayob N, Murray S, et al. Association between Emphysema and
Chronic Obstructive Pulmonary Disease Outcomes in the COPDGene and
SPIROMICS Cohorts: A Post Hoc Analysis of Two Clinical Trials. Am J Respir
Crit Care Med 2018;198:265–7. doi:10.1164/rccm.201801-0051LE
11
Hersh CP, Washko GR, Estépar RSJ, et al. Paired inspiratory-expiratory chest
CT scans to assess for small airways disease in COPD. Respir Res 2013;14:42.
doi:10.1186/1465-9921-14-42
12
Schroeder JD, McKenzie AS, Zach JA, et al. Relationships between airflow
obstruction and quantitative CT measurements of emphysema, air trapping, and
airways in subjects with and without chronic obstructive pulmonary disease. AJR
Am J Roentgenol 2013;201:W460-70. doi:10.2214/AJR.12.10102
13
Shima H, Tanabe N, Sato S, et al. Lobar distribution of non-emphysematous gas
trapping and lung hyperinflation in chronic obstructive pulmonary disease.
Respir Investig 2020;58:246–54. doi:10.1016/j.resinv.2020.01.001
14
Boueiz A, Chang Y, Cho MH, et al. Lobar Emphysema Distribution Is
Associated With 5-Year Radiological Disease Progression. Chest 2018;153:65–
76. doi:10.1016/j.chest.2017.09.022
Shima H, et al. Thorax 2022;0:1–10. doi: 10.1136/thoraxjnl-2021-218288
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
placed on this supplemental material which has been supplied by the author(s)
Supplemental material
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Thorax
Lynch DA, Austin JHM, Hogg JC, et al. CT-Definable Subtypes of Chronic
Obstructive Pulmonary Disease: A Statement of the Fleischner Society.
Radiology 2015;277:192–205. doi:10.1148/radiol.2015141579
Oguma T, Hirai T, Niimi A, et al. Limitations of airway dimension measurement
on images obtained using multi-detector row computed tomography. PLoS One
2013;8:e76381. doi:10.1371/journal.pone.0076381
Tanabe N, Muro S, Oguma T, et al. Computed tomography assessment of
pharmacological lung volume reduction induced by bronchodilators in COPD.
COPD 2012;9:401–8. doi:10.3109/15412555.2012.674986
Dunican EM, Elicker BM, Gierada DS, et al. Mucus plugs in patients with
asthma linked to eosinophilia and airflow obstruction. J Clin Invest
2018;128:997–1009. doi:10.1172/JCI95693
Dunican EM, Elicker BM, Henry T, et al. Mucus Plugs and Emphysema in the
Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers. Am J
Respir Crit Care Med 2020;:rccm.202006-2248OC. doi:10.1164/rccm.2020062248OC
Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker
provides unique signature for diagnosis of COPD phenotypes and disease
progression. Nat Med 2012;18:1711–5. doi:10.1038/nm.2971
Amelon R, Cao K, Ding K, et al. Three-dimensional characterization of regional
lung deformation. J Biomech 2011;44:2489–95.
doi:10.1016/j.jbiomech.2011.06.009
Gary Doran. PyEMD: Earth Mover’s Distance for Python.
2014.https://github.com/garydoranjr/pyemd (accessed 5 Feb 2021).
Kolouri S, Park S, Thorpe M, et al. Optimal Mass Transport: Signal processing
and machine-learning applications. IEEE Signal Process Mag 2017;34:43–59.
doi:10.1109/MSP.2017.2695801
Kubota M, Kobayashi H, Quanjer PH, et al. Reference values for spirometry,
including vital capacity, in Japanese adults calculated with the LMS method and
compared with previous values. Respir Investig 2014;52:242–50.
doi:10.1016/j.resinv.2014.03.003
Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath
determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720–
35. doi:10.1183/09031936.05.00034905
Stanojevic S, Graham BL, Cooper BG, et al. Official ERS technical standards:
Global Lung Function Initiative reference values for the carbon monoxide
transfer factor for Caucasians. Eur Respir J 2017;50:1700010.
doi:10.1183/13993003.00010-2017
Stocks J, Quanjer PH. Reference values for residual volume, functional residual
capacity and total lung capacity. ATS Workshop on Lung Volume
Measurements. Official Statement of The European Respiratory Society. Eur
Respir J 1995;8:492–506. doi:10.1183/09031936.95.08030492
Jones PW, Harding G, Berry P, et al. Development and first validation of the
COPD Assessment Test. Eur Respir J 2009;34:648–54.
doi:10.1183/09031936.00102509
Tsuda T, Suematsu R, Kamohara K, et al. Development of the Japanese version
of the COPD Assessment Test. Respir Investig 2012;50:34–9.
Shima H, et al. Thorax 2022;0:1–10. doi: 10.1136/thoraxjnl-2021-218288
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
placed on this supplemental material which has been supplied by the author(s)
Supplemental material
30
31
32
33
Thorax
doi:10.1016/j.resinv.2012.05.003
Quanjer PH, Pretto JJ, Brazzale DJ, et al. Grading the severity of airways
obstruction: new wine in new bottles. Eur Respir J 2014;43:505–12.
doi:10.1183/09031936.00086313
Moll M, Qiao D, Regan EA, et al. Machine Learning and Prediction of All-Cause
Mortality in COPD. Chest 2020;158:952–64. doi:10.1016/j.chest.2020.02.079
Textor J, van der Zander B, Gilthorpe MS, et al. Robust causal inference using
directed acyclic graphs: the R package ‘dagitty’. Int J Epidemiol 2016;45:1887–
94. doi:10.1093/ije/dyw341
Bhatt SP, Soler X, Wang X, et al. Association between Functional Small Airway
Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. Am J
Respir Crit Care Med 2016;194:178–84. doi:10.1164/rccm.201511-2219OC
Shima H, et al. Thorax 2022;0:1–10. doi: 10.1136/thoraxjnl-2021-218288
...
論文の公開元へ
